Pivot Medical (Sunnyvale, CA) a clinical-stage device company focused on minimally invasive hip restoration technologies, closed a $32M Series C financing. Participants include Adams Street Partners, Delphi Ventures, Montreux Equity Partners and Ivy Capital Partners.

Aviir (Irvine, CA) a commercial-stage diagnostic company focused on pharmacogenomic and genetic tests for risk assessment and therapeutic monitoring of cardiovascular disease and related metabolic disorders, closed a $10M Series E financing. Participants include Merck Global Health Innovation, Bay City Capital, Aberdare Ventures and New Leaf Venture Partners.

Neuraltus Pharmaceuticals (Palo Alto, CA) a clinical-stage biopharmaceutical company focused on small molecule drugs for the neurodegenerative diseases such as ALS multiple sclerosis, Parkinson’s, Alzheimer’s, Fabry’s and Gaucher’s diseases, closed a $9.6M Series B financing. Participants include Latterell Venture Partners, VantagePoint Venture Partners and Adams Street Partners.

Portola Pharmaceuticals (South San Francisco, CA) a clinical-stage small moelcule company focused on acute and chronic cardiovascular and autoimmune and inflammatory diseases, closed an $89M Series E financing. Participants included Temasek, Eastern Capital Limited, D.E. Shaw, Adage Capital Management, BBT Capital Management, Janus Capital Group and Pac-Link BioVentures.

PharmacoFore (San Carlos, CA) a clinical-stage biopharmaceutical company focused on improvement of existing drugs preventing misuse, abuse, and overdose of prescription medications for pain, closed a $10M Series A financing. Participants include Founders Fund.

Edison Pharmaceuticals (Mountain View, CA) a clinical-stage small molecule company focused on mitochondrial disease Friedreich’s ataxia, closed a $4.1M Series E financing. Participants were not identified.
Thanx for your patience as we catch-up.

SeeChange Health (San Francisco, CA) a commercial-stage health management company focused on data analytics and interactive personal health records, closed a $20M Series B financing. Participants include Maverick Capital and Psilos Group.
Thanx for your patience as we catch-up.

SARcode (Brisbane, CA) a clinical-stage biopharmaceutical company focused on chronic T-cell mediated inflammation in ophthalmic and dermatologic disease, closed a $44M Series B financing. Participants include Sofinnova Ventures, Rho Ventures, Alta Partners and Clarus Venture Partners.
Thanx for your patience as we catch-up.

Intuity Medical (Sunnyvale, CA) a clinical-stage diagnostic device company focused on all-in-one blood sample collection and glucose analysis, closed a $12M Series D financing, bringing the total round to $76M. Participants include Accuitive Medical Ventures, Investor Growth Capital, Thomas McNerney, Venrock, Versant Ventures and U.S. Venture Partners.
Thanx for your patience as we catch-up.

Sorbent Therapeutics (Sunnyvale, CA) a clinical-stage biopharmaceutical company focused on development of adaptable non-absorbed polymeric drugs to for congestive heart failure, chronic kidney disease, end stage renal disease and hypertension, closed a $36M Series B financing. Participants include Novartis Venture Funds, Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem.
Thanx for your patience as we [...]

Transcend Medical (Menlo Park, CA) a clinical-stage medical device company focused on the treatment of glaucoma, closed a $16 Series B, bringing the total round to $51M. Participants include Investor Growth Capital, Canaan Partners, Finistere Ventures, HLM Venture Partners, Kaiser Permanente Ventures, Latterell Venture Partners, Morgenthaler Ventures, Split Rock Partners and Technology Partners.
Thanx for your [...]

Restoration Robotics (Mountain View, CA) a clinical-stage medical device company focused on computer assisted image-guidance for hair follicle harvesting, closed a $41M Series C financing. Participants include Clarus Ventures, Sutter Hill Ventures, Alloy Ventures and Interwest.
Thanx for your patience as we catch-up.

Acutus Medical (San Diego, CA) a development-stage medical device company focused on electrophysiological mapping technology for the treatment of cardiac arrhythmias, closed a $1M Series A financing. Participants include Index Ventures.
Thanx for your patience as we catch-up.